Rank | Gene Set | Z-score |
---|---|---|
1 | epoxygenase P450 pathway (GO:0019373) | 9.99214280 |
2 | drug catabolic process (GO:0042737) | 9.56857134 |
3 | regulation of protein activation cascade (GO:2000257) | 8.57948935 |
4 | regulation of complement activation (GO:0030449) | 8.23630553 |
5 | regulation of fibrinolysis (GO:0051917) | 7.77782544 |
6 | glyoxylate metabolic process (GO:0046487) | 7.64425261 |
7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.54279917 |
8 | L-phenylalanine catabolic process (GO:0006559) | 7.54279917 |
9 | ethanol oxidation (GO:0006069) | 7.53409491 |
10 | negative regulation of fibrinolysis (GO:0051918) | 7.16935172 |
11 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.87642834 |
12 | L-phenylalanine metabolic process (GO:0006558) | 6.87642834 |
13 | drug metabolic process (GO:0017144) | 6.49038304 |
14 | urea metabolic process (GO:0019627) | 6.42978453 |
15 | protein carboxylation (GO:0018214) | 6.32798261 |
16 | peptidyl-glutamic acid carboxylation (GO:0017187) | 6.32798261 |
17 | imidazole-containing compound metabolic process (GO:0052803) | 6.11089970 |
18 | oxidative demethylation (GO:0070989) | 5.99044659 |
19 | ethanol metabolic process (GO:0006067) | 5.98050385 |
20 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.91132411 |
21 | nitrogen cycle metabolic process (GO:0071941) | 5.89663721 |
22 | blood coagulation, intrinsic pathway (GO:0007597) | 5.87658485 |
23 | fibrinolysis (GO:0042730) | 5.86664347 |
24 | complement activation, classical pathway (GO:0006958) | 5.83821124 |
25 | * protein activation cascade (GO:0072376) | 5.78161318 |
26 | aromatic amino acid family catabolic process (GO:0009074) | 5.78101280 |
27 | * complement activation (GO:0006956) | 5.74397700 |
28 | bile acid biosynthetic process (GO:0006699) | 5.54675361 |
29 | acute-phase response (GO:0006953) | 5.52422953 |
30 | regulation of triglyceride catabolic process (GO:0010896) | 5.47814350 |
31 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 5.42591016 |
32 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 5.42591016 |
33 | cytolysis (GO:0019835) | 5.41044174 |
34 | urea cycle (GO:0000050) | 5.36154180 |
35 | serine family amino acid catabolic process (GO:0009071) | 5.35346355 |
36 | regulation of humoral immune response (GO:0002920) | 5.33130619 |
37 | regulation of plasminogen activation (GO:0010755) | 5.18337936 |
38 | negative regulation of protein activation cascade (GO:2000258) | 4.96251970 |
39 | bile acid metabolic process (GO:0008206) | 4.93579871 |
40 | cellular glucuronidation (GO:0052695) | 4.89275939 |
41 | * opsonization (GO:0008228) | 4.88836364 |
42 | phenylpropanoid metabolic process (GO:0009698) | 4.88137465 |
43 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.76989191 |
44 | negative regulation of sterol transport (GO:0032372) | 4.70799926 |
45 | negative regulation of cholesterol transport (GO:0032375) | 4.70799926 |
46 | S-adenosylmethionine metabolic process (GO:0046500) | 4.68753057 |
47 | glycine metabolic process (GO:0006544) | 4.68630753 |
48 | glucuronate metabolic process (GO:0019585) | 4.63389917 |
49 | uronic acid metabolic process (GO:0006063) | 4.63389917 |
50 | tyrosine metabolic process (GO:0006570) | 4.61416014 |
51 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.55803138 |
52 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.55803138 |
53 | negative regulation of hemostasis (GO:1900047) | 4.52723235 |
54 | negative regulation of blood coagulation (GO:0030195) | 4.52723235 |
55 | glutamate metabolic process (GO:0006536) | 4.47368608 |
56 | triglyceride homeostasis (GO:0070328) | 4.44429896 |
57 | acylglycerol homeostasis (GO:0055090) | 4.44429896 |
58 | bile acid and bile salt transport (GO:0015721) | 4.41355949 |
59 | plasma lipoprotein particle remodeling (GO:0034369) | 4.24186603 |
60 | protein-lipid complex remodeling (GO:0034368) | 4.24186603 |
61 | macromolecular complex remodeling (GO:0034367) | 4.24186603 |
62 | indolalkylamine catabolic process (GO:0046218) | 4.21498047 |
63 | tryptophan catabolic process (GO:0006569) | 4.21498047 |
64 | indole-containing compound catabolic process (GO:0042436) | 4.21498047 |
65 | negative regulation of coagulation (GO:0050819) | 4.09563799 |
66 | negative regulation of wound healing (GO:0061045) | 4.07278651 |
67 | acute inflammatory response (GO:0002526) | 3.96388798 |
68 | alpha-amino acid catabolic process (GO:1901606) | 3.93539453 |
69 | negative regulation of complement activation (GO:0045916) | 3.92999093 |
70 | high-density lipoprotein particle remodeling (GO:0034375) | 3.91077339 |
71 | positive regulation of blood coagulation (GO:0030194) | 3.86214934 |
72 | positive regulation of hemostasis (GO:1900048) | 3.86214934 |
73 | cholesterol efflux (GO:0033344) | 3.84628113 |
74 | alkaloid metabolic process (GO:0009820) | 3.84489177 |
75 | cellular ketone body metabolic process (GO:0046950) | 3.78726279 |
76 | aromatic amino acid family metabolic process (GO:0009072) | 3.78362562 |
77 | regulation of acute inflammatory response (GO:0002673) | 3.73487187 |
78 | phospholipid efflux (GO:0033700) | 3.66395145 |
79 | amino-acid betaine metabolic process (GO:0006577) | 3.66144935 |
80 | reverse cholesterol transport (GO:0043691) | 3.62735607 |
81 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.62524024 |
82 | tryptophan metabolic process (GO:0006568) | 3.61295190 |
83 | serine family amino acid metabolic process (GO:0009069) | 3.59354762 |
84 | arginine metabolic process (GO:0006525) | 3.57995982 |
85 | flavonoid metabolic process (GO:0009812) | 3.55715171 |
86 | oxaloacetate metabolic process (GO:0006107) | 3.54939861 |
87 | positive regulation of coagulation (GO:0050820) | 3.52738308 |
88 | regulation of apoptotic cell clearance (GO:2000425) | 3.49101600 |
89 | xenobiotic metabolic process (GO:0006805) | 3.44319021 |
90 | positive regulation of lipid catabolic process (GO:0050996) | 3.40536960 |
91 | negative regulation of lipase activity (GO:0060192) | 3.38650247 |
92 | regulation of cholesterol esterification (GO:0010872) | 3.36060196 |
93 | cellular amino acid catabolic process (GO:0009063) | 3.35406884 |
94 | hormone catabolic process (GO:0042447) | 3.33439191 |
95 | sodium-independent organic anion transport (GO:0043252) | 3.32862214 |
96 | ketone body metabolic process (GO:1902224) | 3.31573157 |
97 | response to mercury ion (GO:0046689) | 3.31397618 |
98 | exogenous drug catabolic process (GO:0042738) | 10.3697787 |
99 | omega-hydroxylase P450 pathway (GO:0097267) | 10.3024832 |
100 | complement activation, alternative pathway (GO:0006957) | 10.1513564 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.79817483 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.74188486 |
3 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.74021139 |
4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.60986784 |
5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.53634286 |
6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.05228342 |
7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.95874905 |
8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.61899349 |
9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.75434674 |
10 | HTT_18923047_ChIP-ChIP_STHdh_Human | 2.00332022 |
11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.1170403 |
12 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.99613276 |
13 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.93757435 |
14 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.84004524 |
15 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.79631589 |
16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.70379447 |
17 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.65295506 |
18 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.41093154 |
19 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.40651879 |
20 | GATA1_22025678_ChIP-Seq_K562_Human | 1.38737055 |
21 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.34538250 |
22 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.28699364 |
23 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.19743511 |
24 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.15776467 |
25 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.15392031 |
26 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.06020886 |
27 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.04019093 |
28 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.01910942 |
29 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.98115313 |
30 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.97128601 |
31 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.96462278 |
32 | CBP_21632823_ChIP-Seq_H3396_Human | 0.94703951 |
33 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.89782392 |
34 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.89166464 |
35 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.85492017 |
36 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.85448046 |
37 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.83225474 |
38 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.82996541 |
39 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.82476603 |
40 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.80612232 |
41 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.78018120 |
42 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.75442674 |
43 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.74166256 |
44 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.73307556 |
45 | NFYA_21822215_ChIP-Seq_K562_Human | 0.71390154 |
46 | AR_20517297_ChIP-Seq_VCAP_Human | 0.70322349 |
47 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.69360303 |
48 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.68694137 |
49 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.67884732 |
50 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.67780858 |
51 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.65638670 |
52 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.64139965 |
53 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.63761189 |
54 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.63680421 |
55 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.63565983 |
56 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61762336 |
57 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.61268473 |
58 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.59489172 |
59 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.59258943 |
60 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.58944802 |
61 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.57963890 |
62 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.57835817 |
63 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.56804817 |
64 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.56346889 |
65 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.56240083 |
66 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.56057192 |
67 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.55665150 |
68 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.55619199 |
69 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.55247827 |
70 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.55222739 |
71 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.55169733 |
72 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.54983896 |
73 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.54815291 |
74 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.54446070 |
75 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.54391994 |
76 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.54092525 |
77 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.53559886 |
78 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.53460825 |
79 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.53282823 |
80 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.52495745 |
81 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.51391267 |
82 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.51383062 |
83 | * MYC_19829295_ChIP-Seq_ESCs_Human | 0.51170697 |
84 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.51165447 |
85 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.51036537 |
86 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.51026176 |
87 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.50884159 |
88 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.50733506 |
89 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.50597512 |
90 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.49802191 |
91 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.49722927 |
92 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.48765250 |
93 | NFYB_21822215_ChIP-Seq_K562_Human | 0.48585233 |
94 | SA1_27219007_Chip-Seq_Bcells_Human | 0.48208258 |
95 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.48021207 |
96 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.47451889 |
97 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.47395118 |
98 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.47330323 |
99 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.46556138 |
100 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46286149 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 9.12941213 |
2 | MP0008875_abnormal_xenobiotic_pharmacok | 6.46026398 |
3 | MP0005085_abnormal_gallbladder_physiolo | 5.99998176 |
4 | MP0005360_urolithiasis | 5.57347341 |
5 | MP0005365_abnormal_bile_salt | 5.32056679 |
6 | MP0003195_calcinosis | 4.75826928 |
7 | MP0002138_abnormal_hepatobiliary_system | 4.21998899 |
8 | MP0003252_abnormal_bile_duct | 3.98507179 |
9 | MP0003191_abnormal_cellular_cholesterol | 3.50521340 |
10 | MP0010329_abnormal_lipoprotein_level | 2.99136795 |
11 | MP0001666_abnormal_nutrient_absorption | 2.80978455 |
12 | MP0010368_abnormal_lymphatic_system | 2.66184492 |
13 | MP0005670_abnormal_white_adipose | 2.45486335 |
14 | MP0005332_abnormal_amino_acid | 2.41605723 |
15 | MP0003868_abnormal_feces_composition | 2.40191551 |
16 | MP0009697_abnormal_copulation | 1.99399005 |
17 | MP0000609_abnormal_liver_physiology | 1.99141962 |
18 | MP0002118_abnormal_lipid_homeostasis | 1.88558828 |
19 | MP0009840_abnormal_foam_cell | 1.86779953 |
20 | MP0003806_abnormal_nucleotide_metabolis | 1.85210853 |
21 | MP0001764_abnormal_homeostasis | 1.62972180 |
22 | MP0002876_abnormal_thyroid_physiology | 1.54846626 |
23 | MP0001661_extended_life_span | 1.45080660 |
24 | MP0002132_abnormal_respiratory_system | 1.37923499 |
25 | MP0009764_decreased_sensitivity_to | 1.37826446 |
26 | MP0002971_abnormal_brown_adipose | 1.27681919 |
27 | MP0003656_abnormal_erythrocyte_physiolo | 1.26982706 |
28 | MP0009053_abnormal_anal_canal | 1.26112794 |
29 | MP0009763_increased_sensitivity_to | 1.14471202 |
30 | MP0004019_abnormal_vitamin_homeostasis | 1.10227730 |
31 | MP0005319_abnormal_enzyme/_coenzyme | 1.09674317 |
32 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.09593289 |
33 | MP0000598_abnormal_liver_morphology | 1.09567558 |
34 | MP0004130_abnormal_muscle_cell | 1.07819337 |
35 | MP0002282_abnormal_trachea_morphology | 1.06218006 |
36 | MP0009643_abnormal_urine_homeostasis | 0.96988198 |
37 | MP0005408_hypopigmentation | 0.94266077 |
38 | MP0009642_abnormal_blood_homeostasis | 0.94002169 |
39 | MP0008872_abnormal_physiological_respon | 0.93215484 |
40 | MP0005535_abnormal_body_temperature | 0.91976993 |
41 | MP0005451_abnormal_body_composition | 0.91396300 |
42 | MP0005334_abnormal_fat_pad | 0.90373273 |
43 | MP0008469_abnormal_protein_level | 0.87180706 |
44 | MP0000604_amyloidosis | 0.86446099 |
45 | MP0005376_homeostasis/metabolism_phenot | 0.85409261 |
46 | MP0009785_altered_susceptibility_to | 0.85385553 |
47 | MP0003011_delayed_dark_adaptation | 0.84932297 |
48 | MP0003690_abnormal_glial_cell | 0.84851619 |
49 | MP0005636_abnormal_mineral_homeostasis | 0.84729573 |
50 | MP0002249_abnormal_larynx_morphology | 0.84214832 |
51 | MP0003186_abnormal_redox_activity | 0.82388876 |
52 | MP0005464_abnormal_platelet_physiology | 0.79230524 |
53 | MP0005666_abnormal_adipose_tissue | 0.75747545 |
54 | MP0002078_abnormal_glucose_homeostasis | 0.74215814 |
55 | MP0005266_abnormal_metabolism | 0.73759358 |
56 | MP0001915_intracranial_hemorrhage | 0.72932179 |
57 | MP0003879_abnormal_hair_cell | 0.72369045 |
58 | MP0009765_abnormal_xenobiotic_induced | 0.71567651 |
59 | MP0008874_decreased_physiological_sensi | 0.71545125 |
60 | MP0005166_decreased_susceptibility_to | 0.70053052 |
61 | MP0002332_abnormal_exercise_endurance | 0.64299306 |
62 | MP0005023_abnormal_wound_healing | 0.62254464 |
63 | MP0003075_altered_response_to | 0.58063085 |
64 | MP0000639_abnormal_adrenal_gland | 0.57022443 |
65 | MP0005187_abnormal_penis_morphology | 0.56968558 |
66 | MP0009115_abnormal_fat_cell | 0.55965242 |
67 | MP0002168_other_aberrant_phenotype | 0.54058942 |
68 | MP0005448_abnormal_energy_balance | 0.53889123 |
69 | MP0001545_abnormal_hematopoietic_system | 0.53649591 |
70 | MP0005397_hematopoietic_system_phenotyp | 0.53649591 |
71 | MP0000249_abnormal_blood_vessel | 0.53146596 |
72 | MP0005395_other_phenotype | 0.52502369 |
73 | MP0001881_abnormal_mammary_gland | 0.45517327 |
74 | MP0000467_abnormal_esophagus_morphology | 0.45463968 |
75 | MP0006036_abnormal_mitochondrial_physio | 0.45449510 |
76 | MP0003705_abnormal_hypodermis_morpholog | 0.45332758 |
77 | MP0003638_abnormal_response/metabolism_ | 0.43904440 |
78 | MP0005083_abnormal_biliary_tract | 0.41049432 |
79 | MP0004883_abnormal_blood_vessel | 0.39220528 |
80 | MP0003953_abnormal_hormone_level | 0.39212096 |
81 | MP0005164_abnormal_response_to | 0.37463554 |
82 | MP0003436_decreased_susceptibility_to | 0.35746336 |
83 | MP0005375_adipose_tissue_phenotype | 0.34991790 |
84 | MP0004782_abnormal_surfactant_physiolog | 0.34776087 |
85 | MP0002136_abnormal_kidney_physiology | 0.34228266 |
86 | MP0002970_abnormal_white_adipose | 0.33244321 |
87 | MP0005377_hearing/vestibular/ear_phenot | 0.33064895 |
88 | MP0003878_abnormal_ear_physiology | 0.33064895 |
89 | MP0001845_abnormal_inflammatory_respons | 0.32582922 |
90 | MP0005595_abnormal_vascular_smooth | 0.31555031 |
91 | MP0005647_abnormal_sex_gland | 0.30075449 |
92 | MP0001851_eye_inflammation | 0.29486564 |
93 | MP0002909_abnormal_adrenal_gland | 0.28231309 |
94 | MP0002419_abnormal_innate_immunity | 0.27887410 |
95 | MP0002128_abnormal_blood_circulation | 0.26742232 |
96 | MP0006292_abnormal_olfactory_placode | 0.26739888 |
97 | MP0002295_abnormal_pulmonary_circulatio | 0.25506430 |
98 | MP0000678_abnormal_parathyroid_gland | 0.25235952 |
99 | MP0010155_abnormal_intestine_physiology | 0.24274691 |
100 | MP0003959_abnormal_lean_body | 0.24236701 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of complement system (HP:0005339) | 9.73936208 |
2 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 9.11900259 |
3 | Deep venous thrombosis (HP:0002625) | 9.00396366 |
4 | Prolonged partial thromboplastin time (HP:0003645) | 8.81544796 |
5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 8.22046337 |
6 | Systemic lupus erythematosus (HP:0002725) | 7.14715683 |
7 | Conjugated hyperbilirubinemia (HP:0002908) | 7.09105886 |
8 | Hypobetalipoproteinemia (HP:0003563) | 6.91303377 |
9 | Joint hemorrhage (HP:0005261) | 6.63575895 |
10 | Hyperlipoproteinemia (HP:0010980) | 6.19847365 |
11 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.16831751 |
12 | Glomerulonephritis (HP:0000099) | 5.50020198 |
13 | Spontaneous abortion (HP:0005268) | 5.15855892 |
14 | Intrahepatic cholestasis (HP:0001406) | 4.91947583 |
15 | Xanthomatosis (HP:0000991) | 4.82871391 |
16 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.76060573 |
17 | Abnormality of the common coagulation pathway (HP:0010990) | 4.51484356 |
18 | Abnormality of the intrinsic pathway (HP:0010989) | 4.49324930 |
19 | Hypolipoproteinemia (HP:0010981) | 4.17236881 |
20 | Nephritis (HP:0000123) | 4.15911190 |
21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.80246888 |
22 | Abnormality of methionine metabolism (HP:0010901) | 3.75413594 |
23 | Hypoalphalipoproteinemia (HP:0003233) | 3.71863167 |
24 | Neonatal hypoglycemia (HP:0001998) | 3.49131369 |
25 | Gingival bleeding (HP:0000225) | 3.33535479 |
26 | Thrombophlebitis (HP:0004418) | 3.01109496 |
27 | Hyperglycinemia (HP:0002154) | 2.98326029 |
28 | Hyperammonemia (HP:0001987) | 2.93613395 |
29 | Fat malabsorption (HP:0002630) | 2.82753560 |
30 | Delayed CNS myelination (HP:0002188) | 2.82487302 |
31 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.78898332 |
32 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.69914956 |
33 | Epidermoid cyst (HP:0200040) | 2.64570287 |
34 | Generalized aminoaciduria (HP:0002909) | 2.62021667 |
35 | Hyperbilirubinemia (HP:0002904) | 2.57842572 |
36 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.57569033 |
37 | Abnormality of nucleobase metabolism (HP:0010932) | 2.57439968 |
38 | Purpura (HP:0000979) | 2.57391117 |
39 | Hypercholesterolemia (HP:0003124) | 2.56133363 |
40 | Mitral stenosis (HP:0001718) | 2.51196007 |
41 | Hepatocellular carcinoma (HP:0001402) | 2.50556092 |
42 | Fair hair (HP:0002286) | 2.47395784 |
43 | Abnormality of glycine metabolism (HP:0010895) | 2.46358854 |
44 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.46358854 |
45 | Hemorrhage of the eye (HP:0011885) | 2.44033188 |
46 | Pulmonary embolism (HP:0002204) | 2.42388116 |
47 | Abnormality of serum amino acid levels (HP:0003112) | 2.25579215 |
48 | Joint swelling (HP:0001386) | 2.21964178 |
49 | Abnormality of iron homeostasis (HP:0011031) | 2.21879198 |
50 | Osteomalacia (HP:0002749) | 2.21631192 |
51 | Ketosis (HP:0001946) | 2.11205080 |
52 | Menorrhagia (HP:0000132) | 2.09006820 |
53 | Steatorrhea (HP:0002570) | 2.06786981 |
54 | Rickets (HP:0002748) | 2.06247546 |
55 | Vascular calcification (HP:0004934) | 2.04912156 |
56 | Complement deficiency (HP:0004431) | 12.0594925 |
57 | Epistaxis (HP:0000421) | 1.98460640 |
58 | Increased serum ferritin (HP:0003281) | 1.97257163 |
59 | Cholelithiasis (HP:0001081) | 1.96670827 |
60 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.96177182 |
61 | Metabolic acidosis (HP:0001942) | 1.94333455 |
62 | Myocardial infarction (HP:0001658) | 1.91138290 |
63 | Elevated alkaline phosphatase (HP:0003155) | 1.89793791 |
64 | Hyperglycinuria (HP:0003108) | 1.88780687 |
65 | Cardiovascular calcification (HP:0011915) | 1.82904588 |
66 | Abnormal gallbladder morphology (HP:0012437) | 1.82736902 |
67 | Generalized hypopigmentation of hair (HP:0011358) | 1.77947553 |
68 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.77768148 |
69 | Atrioventricular block (HP:0001678) | 1.76520346 |
70 | Cerebral palsy (HP:0100021) | 1.76423864 |
71 | Gangrene (HP:0100758) | 1.75055383 |
72 | Skin nodule (HP:0200036) | 1.74197636 |
73 | Amyloidosis (HP:0011034) | 1.73493754 |
74 | Hyperphosphaturia (HP:0003109) | 1.72983146 |
75 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.72904210 |
76 | Increased serum pyruvate (HP:0003542) | 1.72440404 |
77 | Abnormal delivery (HP:0001787) | 1.69746540 |
78 | Increased mean platelet volume (HP:0011877) | 1.68121332 |
79 | Enlarged kidneys (HP:0000105) | 1.59612315 |
80 | Reduced antithrombin III activity (HP:0001976) | 1.59051099 |
81 | Neonatal onset (HP:0003623) | 1.58402431 |
82 | Abnormality of purine metabolism (HP:0004352) | 1.57238857 |
83 | Irritability (HP:0000737) | 1.55867889 |
84 | Pancreatitis (HP:0001733) | 1.55395685 |
85 | Blue irides (HP:0000635) | 1.55282496 |
86 | Abnormal platelet volume (HP:0011876) | 1.54380751 |
87 | Arthropathy (HP:0003040) | 1.53710995 |
88 | Gout (HP:0001997) | 1.53580678 |
89 | Spontaneous hematomas (HP:0007420) | 1.51638680 |
90 | Hypertriglyceridemia (HP:0002155) | 1.50949419 |
91 | Abnormality of vitamin metabolism (HP:0100508) | 1.47894438 |
92 | Poikilocytosis (HP:0004447) | 1.47488335 |
93 | Glycosuria (HP:0003076) | 1.46646364 |
94 | Abnormality of urine glucose concentration (HP:0011016) | 1.46646364 |
95 | Abnormality of glycolysis (HP:0004366) | 1.46037928 |
96 | Hypophosphatemic rickets (HP:0004912) | 1.44542759 |
97 | Abnormal platelet function (HP:0011869) | 1.41847104 |
98 | Impaired platelet aggregation (HP:0003540) | 1.41847104 |
99 | Visceral angiomatosis (HP:0100761) | 1.41004354 |
100 | Abnormal gallbladder physiology (HP:0012438) | 1.40038849 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ERN1 | 4.73178099 |
2 | PIK3CG | 3.57606231 |
3 | TRIB3 | 3.56981826 |
4 | SIK1 | 3.36211037 |
5 | FGFR4 | 2.81779211 |
6 | BLK | 2.80398444 |
7 | PRPF4B | 2.80075902 |
8 | BCKDK | 2.75745196 |
9 | EPHA3 | 2.64324388 |
10 | TYK2 | 2.55159822 |
11 | RIPK1 | 2.41751606 |
12 | MAP2K4 | 1.87880234 |
13 | KDR | 1.86991673 |
14 | PRKAA2 | 1.80485433 |
15 | MAP3K12 | 1.77678007 |
16 | MAP4K1 | 1.76166196 |
17 | PRKACG | 1.74253031 |
18 | TAOK2 | 1.64145229 |
19 | CAMKK2 | 1.64049257 |
20 | NTRK3 | 1.63529852 |
21 | JAK1 | 1.59472436 |
22 | MYLK | 1.57991335 |
23 | MAP3K11 | 1.57295527 |
24 | PIK3CA | 1.52556031 |
25 | CSF1R | 1.44376343 |
26 | EPHB1 | 1.42165961 |
27 | TAOK3 | 1.40882303 |
28 | MAP3K3 | 1.37689529 |
29 | TNK2 | 1.36918451 |
30 | PDPK1 | 1.35123764 |
31 | AKT3 | 1.34753452 |
32 | ABL2 | 1.33422147 |
33 | PDK1 | 1.26031382 |
34 | PKN2 | 1.22146158 |
35 | TIE1 | 1.21997741 |
36 | MAP3K1 | 1.18505778 |
37 | IGF1R | 1.14009010 |
38 | JAK2 | 1.13698276 |
39 | MAP3K5 | 1.11629617 |
40 | MAPKAPK3 | 1.10117410 |
41 | CAMKK1 | 1.09822290 |
42 | MAPK11 | 1.05623761 |
43 | NLK | 1.05015698 |
44 | TGFBR2 | 0.99406717 |
45 | FER | 0.98328268 |
46 | MAP3K6 | 0.97086131 |
47 | ERBB2 | 0.92238413 |
48 | ZAP70 | 0.91159502 |
49 | CAMK1D | 0.90527838 |
50 | SCYL2 | 0.90288416 |
51 | FGFR3 | 0.90165793 |
52 | MAPK12 | 0.85350170 |
53 | RET | 0.84562742 |
54 | MAPK4 | 0.75123803 |
55 | MAPK7 | 0.74906801 |
56 | PRKACA | 0.70156429 |
57 | NEK9 | 0.70106058 |
58 | PRKG1 | 0.69338656 |
59 | TBK1 | 0.67366015 |
60 | MAP3K13 | 0.66484077 |
61 | CDK6 | 0.64689389 |
62 | PRKCZ | 0.63426103 |
63 | CAMK4 | 0.62265036 |
64 | PRKCG | 0.61021380 |
65 | PRKAA1 | 0.59142579 |
66 | ARAF | 0.57941728 |
67 | ADRBK1 | 0.55903956 |
68 | DAPK2 | 0.52747133 |
69 | PRKD1 | 0.50058812 |
70 | PTK6 | 0.49903034 |
71 | INSRR | 0.48737455 |
72 | MAPK3 | 0.46025729 |
73 | SYK | 0.42342385 |
74 | IKBKE | 0.37856394 |
75 | MAP2K3 | 0.37177843 |
76 | RPS6KA3 | 0.36869315 |
77 | PRKCA | 0.36625870 |
78 | DYRK1B | 0.35453686 |
79 | PINK1 | 0.35157509 |
80 | GSK3A | 0.34209863 |
81 | MELK | 0.33503033 |
82 | PRKACB | 0.33073625 |
83 | ICK | 0.32225356 |
84 | DDR2 | 0.31598468 |
85 | MST1R | 0.31327529 |
86 | CDK4 | 0.30982878 |
87 | IRAK1 | 0.30886877 |
88 | SRC | 0.30015679 |
89 | LCK | 0.28834077 |
90 | CAMK2G | 0.28641879 |
91 | JAK3 | 0.27276389 |
92 | PRKCQ | 0.24776864 |
93 | SGK3 | 0.24603174 |
94 | PRKCB | 0.24113843 |
95 | KIT | 0.24019271 |
96 | FYN | 0.23395827 |
97 | AKT2 | 0.22819691 |
98 | TESK2 | 0.22299286 |
99 | LYN | 0.20397126 |
100 | MAPK15 | 0.20239130 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.74341845 |
2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 4.36296753 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.34635212 |
4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.56455941 |
5 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.53658217 |
6 | Retinol metabolism_Homo sapiens_hsa00830 | 3.40943566 |
7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.94113830 |
8 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.85495441 |
9 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.76926211 |
10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.68243775 |
11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.67771426 |
12 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.64035699 |
13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.55288794 |
14 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.54366199 |
15 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.37876749 |
16 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.27856247 |
17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.22318823 |
18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.14250819 |
19 | Histidine metabolism_Homo sapiens_hsa00340 | 2.13034266 |
20 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.12153895 |
21 | Prion diseases_Homo sapiens_hsa05020 | 1.91160828 |
22 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.84004671 |
23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.79365298 |
24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.73100347 |
25 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.56562840 |
26 | Bile secretion_Homo sapiens_hsa04976 | 1.55879114 |
27 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.53589174 |
28 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.49754017 |
29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.45595490 |
30 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.43553863 |
31 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.42144467 |
32 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.34557496 |
33 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.30255138 |
34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.23390983 |
35 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.19353739 |
36 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.17557514 |
37 | Peroxisome_Homo sapiens_hsa04146 | 1.11507231 |
38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.08241178 |
39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.07625944 |
40 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.05617504 |
41 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.98492971 |
42 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.93726058 |
43 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.85831409 |
44 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.84383398 |
45 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.80976670 |
46 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.80367082 |
47 | ABC transporters_Homo sapiens_hsa02010 | 0.79504148 |
48 | Carbon metabolism_Homo sapiens_hsa01200 | 0.78540947 |
49 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.78252675 |
50 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.72535249 |
51 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.71264382 |
52 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.67573684 |
53 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.65508788 |
54 | Pertussis_Homo sapiens_hsa05133 | 0.51053576 |
55 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.42909051 |
56 | Metabolic pathways_Homo sapiens_hsa01100 | 0.38739850 |
57 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.35888522 |
58 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.33927506 |
59 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.33647774 |
60 | Lysine degradation_Homo sapiens_hsa00310 | 0.33366862 |
61 | Insulin resistance_Homo sapiens_hsa04931 | 0.33106778 |
62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.32265453 |
63 | Sulfur relay system_Homo sapiens_hsa04122 | 0.31479951 |
64 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.30110341 |
65 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.22958769 |
66 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21643865 |
67 | Amoebiasis_Homo sapiens_hsa05146 | 0.19350943 |
68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.18474311 |
69 | Mineral absorption_Homo sapiens_hsa04978 | 0.16030356 |
70 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.14381077 |
71 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.13168928 |
72 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.12963931 |
73 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.08308055 |
74 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.02622350 |
75 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.02438350 |
76 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.00815622 |
77 | Prolactin signaling pathway_Homo sapiens_hsa04917 | -0.2665238 |
78 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2501149 |
79 | FoxO signaling pathway_Homo sapiens_hsa04068 | -0.2359722 |
80 | Platelet activation_Homo sapiens_hsa04611 | -0.2335691 |
81 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.2260210 |
82 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.2235982 |
83 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1798265 |
84 | Steroid biosynthesis_Homo sapiens_hsa00100 | -0.1656975 |
85 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.1620616 |
86 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1554993 |
87 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.1316237 |
88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1198964 |
89 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.1185620 |
90 | Glutathione metabolism_Homo sapiens_hsa00480 | -0.1152589 |
91 | Other glycan degradation_Homo sapiens_hsa00511 | -0.1129983 |
92 | Galactose metabolism_Homo sapiens_hsa00052 | -0.1081311 |
93 | Nitrogen metabolism_Homo sapiens_hsa00910 | -0.0961271 |
94 | Folate biosynthesis_Homo sapiens_hsa00790 | -0.0825702 |
95 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0709631 |
96 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0698985 |
97 | Selenocompound metabolism_Homo sapiens_hsa00450 | -0.0697239 |
98 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0545443 |
99 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0519784 |
100 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | -0.0475298 |